Return to homepagePandemic Pact

CoVPN Vaccine Site Preparation

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Known Financial Commitments (USD)

    $101,206,482

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    MYRON S COHEN

  • Research Location

    United States of America

  • Lead Research Institution

    FAMILY HEALTH INTERNATIONAL

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 3 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase III

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Project Summary/AbstractGiven the rapid spread of SARS-CoV-2 infection, the on-going global pandemic, and the risk for seasonalrecurrence there is a critical need to test emerging vaccine candidates in phase 3 efficacy trials. Due toits experience in implementation of global HIVAIDS prevention efficacy trials and its operational capacityto respond to a new global pandemic, the HPTN, in collaboration with the HVTN, is providing operationalsupport for the newly constituted COVID-19 Prevention Network (CoVPN). Preparing for a series oflarge scale efficacy trials, this application outlines aims required to build the infrastructure capacity torapidly implement them over the coming month. The requested funds are to prepare clinical trial sitesfor implementation of these trials. The HPTN will support 30 clinical trials sites in the United States,South America, and Sub-Saharan Africa so they can begin enrollment in NIH supported COVID-19 vaccineand monoclonal trials planned for implementation over the next 6 months.